Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arjun Lakshman

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|December 23, 2015
Predictive Value of Glycated Hemoglobin and Body Mass Index for Pretreatment Neuropathy in Patients With Multiple MyelomaArjun Lakshman, Manish Modi, Gaurav Prakash, et al.
Environmental Geochemistry and Health|June 4, 2020
Health risk assessment of heavy metals and strontium in groundwater used for drinking and cooking in 58 villages of Prakasam district, Andhra Pradesh, IndiaArjun Lakshman Khandare, Vakdevi Validandi, Ananthan Rajendran, et al.
The Journal of the Association of Physicians of India|September 27, 2019
Pulmonary and Ear, Nose and Throat (ENT) Involvement in ANCA-Associated Vasculitis at Diagnosis-Experience from a Tertiary Care Centre in North IndiaAman Sharma, Arjun Lakshman, Ram V Nampoothiri, et al.
Research Square|November 14, 2023
Mode of Progression in Smoldering Multiple Myeloma: A study of 406 patientsS Rajkumar, Nadine Abdallah, Arjun Lakshman, et al.
Blood Cancer Journal|January 16, 2024
Mode of progression in smoldering multiple myeloma: a study of 406 patientsNadine H Abdallah, Arjun Lakshman, Shaji K Kumar, et al.
American Journal of Hematology|August 12, 2017
Efficacy of daratumumab-based therapies in patients with relapsed, refractory multiple myeloma treated outside of clinical trialsArjun Lakshman, Jithma P Abeykoon, Shaji K Kumar, et al.
American Journal of Hematology|October 26, 2017
Efficacy of VDT PACE-like regimens in treatment of relapsed/refractory multiple myelomaArjun Lakshman, Preet Paul Singh, S Vincent Rajkumar, et al.
Blood Advances|November 23, 2018
Plasma cell proliferative index is an independent predictor of progression in smoldering multiple myelomaMohammed A Aljama, M Hasib Sidiqi, Arjun Lakshman, et al.
Blood Cancer Journal|June 14, 2018
Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteriaArjun Lakshman, S Vincent Rajkumar, Francis K Buadi, et al.
Blood Advances|June 29, 2019
Impact of acquired del(17p) in multiple myelomaArjun Lakshman, Utkarsh Painuly, S Vincent Rajkumar, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Clinical Lymphoma, Myeloma & Leukemia|December 23, 2015
Predictive Value of Glycated Hemoglobin and Body Mass Index for Pretreatment Neuropathy in Patients With Multiple MyelomaArjun Lakshman, Manish Modi, Gaurav Prakash, et al.
Environmental Geochemistry and Health|June 4, 2020
Health risk assessment of heavy metals and strontium in groundwater used for drinking and cooking in 58 villages of Prakasam district, Andhra Pradesh, IndiaArjun Lakshman Khandare, Vakdevi Validandi, Ananthan Rajendran, et al.
The Journal of the Association of Physicians of India|September 27, 2019
Pulmonary and Ear, Nose and Throat (ENT) Involvement in ANCA-Associated Vasculitis at Diagnosis-Experience from a Tertiary Care Centre in North IndiaAman Sharma, Arjun Lakshman, Ram V Nampoothiri, et al.
Research Square|November 14, 2023
Mode of Progression in Smoldering Multiple Myeloma: A study of 406 patientsS Rajkumar, Nadine Abdallah, Arjun Lakshman, et al.
Blood Cancer Journal|January 16, 2024
Mode of progression in smoldering multiple myeloma: a study of 406 patientsNadine H Abdallah, Arjun Lakshman, Shaji K Kumar, et al.
American Journal of Hematology|August 12, 2017
Efficacy of daratumumab-based therapies in patients with relapsed, refractory multiple myeloma treated outside of clinical trialsArjun Lakshman, Jithma P Abeykoon, Shaji K Kumar, et al.
American Journal of Hematology|October 26, 2017
Efficacy of VDT PACE-like regimens in treatment of relapsed/refractory multiple myelomaArjun Lakshman, Preet Paul Singh, S Vincent Rajkumar, et al.
Blood Advances|November 23, 2018
Plasma cell proliferative index is an independent predictor of progression in smoldering multiple myelomaMohammed A Aljama, M Hasib Sidiqi, Arjun Lakshman, et al.
Blood Cancer Journal|June 14, 2018
Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteriaArjun Lakshman, S Vincent Rajkumar, Francis K Buadi, et al.
Blood Advances|June 29, 2019
Impact of acquired del(17p) in multiple myelomaArjun Lakshman, Utkarsh Painuly, S Vincent Rajkumar, et al.
Pageof 3